使用经过验证且可靠的问卷调查癌症患者，评估完全减充血疗法 (CDT) 对癌症相关疲劳、睡眠质量和淋巴水肿特定生活质量的影响，值得称赞。这项前瞻性研究包括 94 名患有乳房切除术后淋巴水肿综合征的患者。记录患者的人口统计学特征。参与者的淋巴水肿阶段（国际淋巴学会）、平井癌症疲劳量表（HCFS）评分、匹兹堡睡眠质量指数（PSQI）总体评分、淋巴水肿特定生活质量问卷（LYMQOL-ARM）评分和总体健康状况记录CDT前后的状态。患者的平均年龄为58.49±10.96岁。水肿的严重程度与整体健康状况之间存在很强的相关性。 HCFS评分、PSQI全局评分、LYMQOL-ARM评分和CDT之间存在显着正相关关系。去充血物理治疗后，大多数淋巴水肿分期分别下降（p＜＜0.05）。总体健康状况也有改善的趋势 (p<0.05)。乳腺癌女性术后，与癌症相关的疲劳和睡眠障碍可能持续数年。这会对患者的身体、社交和认知产生负面影响。我们的研究是第一项调查乳房切除术后患者的 HCFS 评分以及 PSQI 总体评分与 CDT 之间关系的研究。研究结果确定了影响淋巴水肿女性这些结果的风险因素，并且可以为有针对性的干预措施和改善患者护理提供有价值的见解。© 2024。作者。

To evaluate the effects of complete decongestive therapy (CDT) on cancer-related fatigue, sleep quality, and lymphedema-specific quality of life using validated and reliable questionnaires in cancer patients being commendable.This prospective study includes 94 patients who had postmastectomy lymphedema syndrome. The demographic characteristics of the patients were recorded. The participants' stages of lymphedema (The International Society of Lymphology), Hirai Cancer Fatigue Scale (HCFS) score, Pittsburgh Sleep Quality Index (PSQI) Global score, lymphedema-specific quality of life questionnaire (LYMQOL-ARM) score, and Global health status were recorded before and after CDT.The mean age of the patients was 58.49 ± 10.96 years. Strong correlations were found between the severity of edema and global health status. There was a significant positive relationship between the HCFS score, PSQI Global score, LYMQOL-ARM score, and CDT. After decongestive physiotherapy, the majority of the lymphedema stages were downstaging (p < 0.05), respectively. There was also a trend toward improvement in general well-being (p < 0.05).Cancer-related fatigue and sleep disturbance can persist for years after surgery in women with breast cancer. This can negatively affect the patient physically, socially and cognitively. Our study, which is the first study to investigate the HCFS score in postmastectomy patients and the relationship between PSQI Global score and CDT. The findings identify the risk factors that affect these outcomes in women with lymphedema and can provide valuable insights for targeted interventions and improved patient care.© 2024. The Author(s).